Nick Bayhi
AeroLeads people directory · profile

Nick Bayhi Email & Phone Number

Chief Executive Officer at AddGraft Therapeutics
Location: Chicago, Illinois, United States 18 work roles 3 schools
1 work email found @immunogen.com 1 phone found area 781 LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 1 phone

Work email n****@immunogen.com
Direct phone (781) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Chief Executive Officer
Location
Chicago, Illinois, United States

Who is Nick Bayhi? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Nick Bayhi is listed as Chief Executive Officer at AddGraft Therapeutics, based in Chicago, Illinois, United States. AeroLeads shows a work email signal at immunogen.com, phone signal with area code 781, and a matched LinkedIn profile for Nick Bayhi.

Nick Bayhi previously worked as Biophysical Sciences PhD Student at University Of Chicago and Fellow at Scion Life Sciences. Nick Bayhi holds Doctor Of Philosophy - Phd, Biophysics from University Of Chicago.

Company email context

Email format at AddGraft Therapeutics

This section adds company-level context without repeating Nick Bayhi's masked contact details.

nbayhi@immunogen.com
76% confidence

AeroLeads found 1 current-domain work email signal for Nick Bayhi. Compare company email patterns before reaching out.

Profile bio

About Nick Bayhi

The best way to contact me is to include a note along with your connection request.

Listed skills include Cell Culture, Biomedical Engineering, Research, Biotechnology, and 30 others.

Current workplace

Nick Bayhi's current company

Company context helps verify the profile and gives searchers a useful next step.

AddGraft Therapeutics
Addgraft Therapeutics
Chief Executive Officer
California, United States
AeroLeads page
18 roles · 5 years

Nick Bayhi work experience

A career timeline built from the work history available for this profile.

Chief Executive Officer

Addgraft Therapeutics

California, United States

Biophysical Sciences Phd Student

Current

Chicago, Il, Us

I’m building in vitro and in silico tools to demystify protein conformational dynamics

Aug 2019 - Present

Director Of Activator

Current

Chicago, Il , Us

Jul 2024 - Present

Scientific Advisory Board, Chief Scientific Consultant

Current

Cambridge, Massachusetts, Us

Working with the team to make low-cost biosimilar insulin available to everyone

2022 - Present ~4 yrs 6 mos

Fellow

Washington, District Of Columbia, Us

Engaging with policy efforts to make medicines more affordable to patients without stifling innovation in the drug industry.

Sep 2024 - Dec 2024

Senior Analyst

Boston, Massachusetts, Us

Sourcing and diligence for early stage life sciences companies, Seed-Series A

Aug 2024 - Nov 2024

Teaching Assistant, Entrepreneurship In Healthcare And Life Sciences

Chicago, Illinois, Us

Curriculum (re)design, assignment support and grading, student support. Course is open to a mix of students from the science and business graduate schools at UChicago. Students are asked to identify novel biotech-focused IP from university tech transfer offices, and develop robust research and business plans to commercialize the technology.

Jun 2024 - Aug 2024

Bio Fellow

New York, Ny, Us

- Diligence for early stage (seed through Series B) biotech investments, with a broad focus: ADCs, MAbs/BsAbs, small molecules, cell therapy, gene delivery (viral/nonviral), DNA sequencing, microneedles, contraception- Led Q&A with C-suites at over 25 companies; lead contributor to diligence on 50+ potential investments- Developed triage habits to identify critical questions from company slide decks and other resources (science literature, PitchBook, GlobalData, UpToDate); presented weekly updates on active deals; sourced deals - Major author of two funded Investment Memos (nonviral gene delivery, antidepressive therapeutics)

Jan 2024 - Jun 2024

Sra, Protein Chemistry

Cambridge, Massachusetts, Us

Led development of cell-surface click conjugation platform to prototype protein constructs for preclinical data- Screened compounds with different reactivity and linker components to maximize protein copy on cell • Created multiple site-specific conjugation techniques to orient protein constructs on the cell surface, better mimicking the presentation and function of constructs surface-expressed in our final product - Bis-alkylation of His-tag and disulfide bonds using bis-sulfone reagents. Engineered Cys with maleimides- Orientation enabled preclinical data for our lead immuno-oncology clinical candidate RTX-212, where nonspecific conjugation yielded inactive protein and would have led to deprioritization of the programExpressed dozens of unique mammalian and bacterial protein constructs to supply 30+ person Discovery team- Cytokines and immune molecules for immuno-oncology and autoimmune indications, tolerance induction - Therapeutic enzymes, including multimeric complexes, for oncology and rare-disease indications- Fc, His, MBP tags; Cell-penetrating peptide moieties; ScFvs for tissue-specific targeting - DNA transformation, production, and preparation from mini- to giga-prep scale• Purified and characterized dozens of unique protein constructs, using AKTA and gravity columns- Protein A and IMAC affinity method development, including screening buffer and elution components- IEX and SEC to improve product purity and quality. Endotoxin removal by IEX, EndoTrap, Mustang E- Developed equations to account for reagent-specific absorption interference when quantifying conjugatesCleaved commercial antibodies into FAbs; purified and labeled for oriented conjugation and targetingProtein construct design for technology development efforts (FRET analysis, site-specific experiments)

Jun 2017 - Aug 2019

Research Associate Ii, Biochemistry

North Chicago, Illinois, Us

Researching and optimizing methods for protein-small molecule conjugation and purification at small to medium scale, and the analysis of those conjugates and their processing in vitro and in vivo. Specific areas of research interest:- Novel cytotoxic and functional payloads- Nontraditional (non-antibody) protein constructs; Site-specific conjugation methods- In vitro processing and intracellular trafficking of various targets, constructs, and payloads- In vivo understanding of where and how conjugates are processed and payloads are released; how the tumor microenvironment can affect a conjugateAnalytical experience includes extensive work using the Thermo Q Exactive mass spectrometer to characterize and quantify whole and reduced antibodies, fragments, digests, and payload catabolites (both standard and radioactive samples). Key projects include:- Major contributions to the platform development of site-specific engineered cysteine conjugation- Using novel payloads to monitor, quantify, and visualize antibody internalization in real-time- Fabricating anti-drug antibody heterodimers for affinity-based drug "conjugation" (used to screen new drug variants)- Synthesizing radiolabeled antibody-drug conjugations used to examine tissue distribution; processing tissue samples to quantify distribution of ADC vs. free drug

Jun 2015 - Jun 2017

Co-Op, Purification Development: Prep-Scale Isolation Of Charged And Drug-Load Variants

South San Francisco, California, Us

• Built AKTA-scale protocols to enrich and isolate charged variants and drug-to-antibody ratio (DAR) variants from MAbs and ADCs using ion exchange and hydrophobic interaction chromatography• Delivered product variants over 25x faster than existing methods; worked to establish this process as the platform for variant collection across departments in Pharma Technical Development

Jan 2015 - Jun 2015

Co-Op, Purification Development: Antibody-Drug Conjugation Process Development, Drug Localization

South San Francisco, California, Us

• Established conjugation process and operating ranges used for Phase I manufacturing• Leveraged size exclusion and hydrophobic interaction chromatography, Bioanalyzer, and Ellman’s assay to evaluate product quality and drug-to-antibody ratio throughout our conjugation process• Pioneered a high-throughput Chip-TOF mass spectrometer method to localize drugs on our THIOMAB without peptide mapping; it has been adopted by the ADC group for early characterization of new ADCs

Jun 2014 - Jan 2015

Biomedical Engineering Researcher

Medford, Massachusetts, Us

2013-2014Thesis: Modular ECM Microcubes for Complex Tissue Constructs• Fabricated decellularized microscale extracellular matrix blocks with native morphology• Developed a protocol for processing ECM structures without digestion or crosslink agents• Built diversely-shaped self-assembled tissues that promote vascularization, cell function• Explanted rat livers and hearts to harvest primary cells and source extracellular matrix2012-2014Senior Capstone: Perfusion Bioreactor for High-Throughput Culture• Invented a high-throughput reusable bioreactor system to maintain over thirty 3D tissue samples in parallel for up to two weeks with automated media recirculation• Verified sample likeness with cell proliferation and function assays, nanoparticle delivery• Poster presentation at Biomedical Engineering Society Conference, Seattle, WA, 2013.Fall 2011Neuron Alignment using Physical and Wireless Electromagnetic Cues• Designed a system to assess the relative effectiveness of micropatterned channels and E- field stimulus arranged independently, in parallel, and competing in parallelSummer 20113D Culture of Hematopoietic Stem Cells as Functional Bone Marrow• Engineered a silk scaffold perfusion device to support prolonged survival of hHSCs• Optimized feeder layer and media conditions to deter differentiation and support growth• Confirmed stem cell identity, engraftment with flow cytometry and confocal microscopy• Acknowledged in Glettig and Kaplan (2013), “Extending Human Hematopoietic Stem Cell Survival In Vitro with Adipocytes,” BioResearch Open Access 2(3): 179-85.Spring 2011Improved Fabrication Techniques for Biocompatible RFID Coils• Analyzed resonance of in-house RFID coils to improve signal specificity and coil assemblyFall 2010Induced Inflammatory Response on Nano-rough Silk Films• Used TNF expression in THP-1 cells to evaluate films with varying shape and treatments

Sep 2010 - Jun 2014

Graduate Writing Consultant

Medford, Massachusetts, Us

• Worked one-on-one with all levels of students and professors in a variety of disciplines • Experience proofreading and copy-editing large scientific and nonscientific manuscripts• Prepared group workshops for technical & ESL tutoring, grant and journal article writing• Presented a 70-minute Technical Writing workshop at the National Conference on Peer Tutoring in Writing, Tampa, FL, 2013.

May 2013 - May 2014

Subject Tutor

Medford, Massachusetts, Us

• Subject tutor for individuals and groups in biology, physics, math, and engineering science.

May 2013 - May 2014

Writing Fellow

Medford, Massachusetts, Us

• Assigned to a new class each semester, I worked with students (graduates and undergraduates) to improve their skills as writers through one-on-one meetings in which we discussed their essay drafts for the class. I met with professors multiple times during the semester to have an in-depth conversation about what they are specifically expecting from students on each assignment, and their grading criteria.Classes I've fellowed include CH1: Intro. to Community Health, BME62/162: Molecular Biotechnology, PS135: Comparative Revolutions, PS 174: The Rise and Fall of Great Powers, and HIST 54: Europe from the French Revolution to Present

Aug 2010 - May 2013
3 education records

Nick Bayhi education

Doctor Of Philosophy - Phd, Biophysics

University Of Chicago

Master Of Science (Ms), Biomedical Engineering

Tufts University

Bachelor Of Science, Biomedical Engineering

Tufts University
FAQ

Frequently asked questions about Nick Bayhi

Quick answers generated from the profile data available on this page.

What company does Nick Bayhi work for?

Nick Bayhi works for AddGraft Therapeutics.

What is Nick Bayhi's role at AddGraft Therapeutics?

Nick Bayhi is listed as Chief Executive Officer at AddGraft Therapeutics.

What is Nick Bayhi's email address?

AeroLeads has found 1 work email signal at @immunogen.com for Nick Bayhi at AddGraft Therapeutics.

What is Nick Bayhi's phone number?

AeroLeads has found 1 phone signal(s) with area code 781 for Nick Bayhi at AddGraft Therapeutics.

Where is Nick Bayhi based?

Nick Bayhi is based in Chicago, Illinois, United States while working with AddGraft Therapeutics.

What companies has Nick Bayhi worked for?

Nick Bayhi has worked for Addgraft Therapeutics, University Of Chicago, Scion Life Sciences, Nucleate Chicago, and Project Insulin.

How can I contact Nick Bayhi?

You can use AeroLeads to view verified contact signals for Nick Bayhi at AddGraft Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Nick Bayhi attend?

Nick Bayhi holds Doctor Of Philosophy - Phd, Biophysics from University Of Chicago.

What skills is Nick Bayhi known for?

Nick Bayhi is listed with skills including Cell Culture, Biomedical Engineering, Research, Biotechnology, Molecular Biology, Cell, Microsoft Office, and Tissue Engineering.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.